CHAR Technologies Announces Hugh Cleland Appointed to Board of Directors
19 Octubre 2021 - 3:01PM
CHAR Technologies Ltd. (“
CHAR” or the “Company”)
(YES – TSXV) is pleased to announce the appointment of Mr. Hugh
Cleland, CFA to the Board of Directors.
Hugh is co-founder and principal at Roadmap
Capital, a venture capital investment platform designed to connect
ultra high net worth investors with opportunities to invest in
companies that have developed disruptive technologies. Roadmap and
its investors have invested more than $180M in VC-stage tech
companies. Sectors include semiconductors, cybersecurity, material
sciences, and medical devices. Mr. Cleland is a member of the Board
of Directors of Ubilite Inc, Perimeter Medical Imaging
(www.perimetermed.com PINK on the TSXV), MMB and Corsa Security,
and is an observer on the Board of Peraso Technologies (
www.perasotech.com ), a 5G semiconductor company which recently
announced a pending go-public transaction on NASDAQ through a
reverse merger with MoSys, Inc. He was founding portfolio manager
at Northern Rivers Capital Management ("Northern Rivers"), where he
managed the Northern Rivers Innovation Fund from May of 2001 until
Northern Rivers was acquired by BluMont Capital in February of
2010, winning the “Opportunistic Strategy Hedge Fund Award” at the
Canadian Investment Awards in 2006. He co-founded Roadmap Capital
Inc. in the summer of 2013. Mr. Cleland has a Bachelor of Arts
(Honours, 1992/97) from Harvard University and earned his CFA
designation in 2001.
Andrew White, CEO states: “We are extremely
pleased to welcome Hugh to the Board. His experience working with
tech companies as they move into the commercialization stage is a
great complement to the CHAR team. We look forward to his
contribution as CHAR broadens its capital markets activities and
works to enhance the Company’s profile as a candidate for
investment by cleantech and ESG focused investors. CHAR's
technology produces renewable natural gas, green hydrogen and a
replacement for metallurgical coal, and is a major step in
achieving the renewable natural gas targets set by leading gas
utility companies.”
Hugh Cleland states: “This is an exciting time
to join the CHAR team as the company progresses from the R&D
and early commercial stage into substantial commercial deployments
with large multinationals wanting to use CHAR’s technology to turn
waste streams into valuable carbon-neutral products. Two of the
aspects of CHAR’s technology that I find exciting are that it has
proven it can process new waste streams that have never before been
converted into renewable natural gas and green hydrogen, and in
solid renewable fuels, it can provide economics that are superior
to fossil fuels – a metric that no other renewable fuel that I am
aware of can meet. The mission to commercialize and proliferate
CHAR’s High Temperature Pyrolysis technology is a perfect fit with
my personal mission to invest in technologies which improve the
human condition and is a great fit for investors with cleantech and
ESG mandates. The current outlook for renewable natural gas,
hydrogen and biofuels is positive and CHAR is well positioned to
benefit from this emerging trend.”
This appointment is subject to TSX Venture
Exchange approval.
About CHAR
CHAR Technologies Ltd. is a cleantech
development and services company, specializing organic waste
pyrolysis and biocarbon development, custom equipment for
industrial air and water treatment, and providing services in
environmental management, site investigation and remediation,
engineering, environmental compliance and resource efficiency.
For further information, please
contact:
Andrew
White |
Mark
Korol |
Chief Executive Officer |
Chief Financial Officer |
CHAR Technologies Ltd. |
CHAR Technologies Ltd. |
E: andrew.white@chartechnologies.com |
E: m.korol@chartechnologies.com |
T: 866 521-3654 |
Website: www.chartechnologies.com |
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Perimeter Medical Imagin... (TSXV:PINK)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Perimeter Medical Imagin... (TSXV:PINK)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024